Flex4Pharma SRL
The score of Flex4Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +34 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Flex4Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Flex4Pharma's financial analysis
- Solvency51.7%sector median: 47.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Flex4Pharma
Flex4Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0755.383.441
- VAT number
- BE0755383441
- Peppol
- Registered · 0208:0755383441 · as of 03 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Sep 2020
- Registered office
- 3090 Overijse
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Flex4Pharma (SRL) has been based in Overijse since 2020, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 18,711 € and equity of 30,751 €; its revenue is not published. Its solvency stands at 51.7%, above the median of its sector (47.8%).
Companies similar to Flex4Pharma
Companies in the same business, of comparable size and area, outside its group.
- Biotops Activities of holding companies Tournai · balance sheet €1.15m
- Vrml Invest Retail sale of medical and orthopaedic goods Mouscron · balance sheet 111,191 €
- Boneva Other non-specialised retail sale Lede · balance sheet 56,484 €
- Labo Conso Dental Retail sale of medical and orthopaedic goods Tournai · balance sheet 192,151 €
- Hoorwinkel Retail sale of medical and orthopaedic goods Antwerp · balance sheet 214,628 €
- WS Orthoconsult Retail sale of medical and orthopaedic goods Zoutleeuw · balance sheet 136,480 €
- Beltragen Retail sale of medical and orthopaedic goods Fléron · balance sheet 254,051 €
- GTO Tailor Made Retail sale of medical and orthopaedic goods Charleroi · balance sheet 269,840 €
Frequently asked questions about Flex4Pharma
What is the revenue of Flex4Pharma?
Flex4Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Flex4Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0755383441 for Flex4Pharma, if the company is VAT-registered. Its company number (CBE) is 0755.383.441.
Where is the registered office of Flex4Pharma?
According to the CBE register, the registered office of Flex4Pharma is in 3090 Overijse.
What is the equity of Flex4Pharma?
At the close of the 2025 financial year, the equity of Flex4Pharma amounts to 30,751 €, a solvency of 51.7% of total assets.
Who manages Flex4Pharma?
The register lists 1 active mandates at Flex4Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Flex4Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →